Current Pharmacogenomics and Personalized Medicine

Formerly Current Pharmacogenomics

Ramón Cacabelos
Institute of Medical Science and Genomic Medicine


Become EABM
Become Reviewer

Most Cited Article

Herbal Drug Discovery: Challenges and Perspectives

Volume:16   Issue:1
Pp: 63-68
Subramani Parasuraman*
DOI: 10.2174/1875692116666180419153313

Oxidative Stress as a Key Signaling Pathway in Placental Angiogenesis Changes in Preeclampsia: Updates in Pathogenesis, Novel Biomarkers and Therapeutics open access plus

Volume:16   Issue:3
Pp: 167-181
Enoch Odame Anto, Peter Roberts, Cornelius Archer Turpin and Wei Wang*
DOI: 10.2174/1875692117666181207120011

Drug Abuse Treatment through Gene Manipulation Using Nanomedicine open access plus

Volume:16   Issue:3
Pp: 182-191
Firoozeh Alavian*
DOI: 10.2174/1875692117666181207120751

Molecular Mechanism of Metformin Associated Lactic Acidosis (MALA)- an In Silico Exploration open access plus

Volume:16   Issue:3
Pp: 199-209
Siddiqur Rahman, Tamim Ahsan, Riajul Hossain, Tasnim Ahmed and Abu Ashfaqur Sajib*
DOI: 10.2174/1875692117666181207121639

Individualized Cancer Therapy, Future Approaches open access plus

Volume:16   Issue:2
Pp: 156-163
Da-Yong Lu*, Ting-Ren Lu, Bin Xu, Jin-Yu Che, Ying Shen and Nagendra Sastry Yarla
DOI: 10.2174/1875692116666180821095434

Validation of Traditional Medicinal Practices through Modern Scientific Tools and Techniques promotion: free to download

Volume:16   Issue:1
Pp: 3-3
Vijay Kothari
DOI: 10.2174/187569211601180716105632

The Gut Microbiota in Cardiovascular Diseases: From Biomarkers and Potential Targets to Personalized Interventions

Volume:16   Issue:1
Pp: 75-85
Yaroslav I. Ashikhmin, Abram L. Syrkin, Andrey A. Zamyatnin Jr.*, Yong Zhang and Philipp Yu. Kopylov*
DOI: 10.2174/1875692116666180511170329

Metabolomics-based Approach to Pharmacotherapy Personalization: Advantages and Limitations open access plus

Volume:16   Issue:3
Pp: 192-198
Dmitry L. Maslov*, Elena E. Balashova, Oxana P. Trifonova and Petr G. Lokhov
DOI: 10.2174/1875692116666181008144905

Computational Studies of Molecular Targets Regarding the Adverse Effects of Isoniazid Drug for Tuberculosis open access plus

Volume:16   Issue:3
Pp: 210-218
Nachimuthu Mohanasundaram and Talluri Sekhar*
DOI: 10.2174/1875692116666181108145230

Association between Paraoxonase 1(PON1) Gene Polymorphisms and PON1 Enzyme Activity in Indian Patients with Coronary Artery Disease (CAD) open access plus

Volume:16   Issue:3
Pp: 219-229
Renuka Munshi*, Falguni Panchal, Ajay Chaurasia and Girish Rajadhyaksha
DOI: 10.2174/1875692117666181227112119

Current Clinical Application and Response Prediction Biomarkers of PARP Inhibitors open access plus

Volume:16   Issue:2
Pp: 108-117
Wei-Hua Shao, Lei-Yun Wang and Ji-Ye Yin*
DOI: 10.2174/1875692116666180821152601

A Prospective Observational Pilot Study of Adverse Drug Reactions in Patients Admitted in the Geriatric Ward of a Tertiary Hospital in North India open access plus

Volume:16   Issue:2
Pp: 147-155
Upinder Kaur, Sankha Shubhra Chakrabarti*, Bhanupriya Singh and Indrajeet Singh Gambhir
DOI: 10.2174/1875692116666180830124924

Evaluation of Estrogen Receptor α and ß Genes Expression in Normal and Neoplastic Mammary Gland in Dogs by Real-time PCR open access plus

Volume:16   Issue:2
Pp: 140-146
M.R. Nassiri*, S.A. Hosseini, S. Ghovvati and M. Zabetian
DOI: 10.2174/1875692116666180907100151

Preface promotion: free to download

Volume:16   Issue:1
Pp: 2-2
Adrian Llerena
DOI: 10.2174/187569211601180716105422

Revisiting the in-vitro Assays for Antifungal Evaluation of Natural Products

Volume:16   Issue:1
Pp: 69-74
Venkata Saibabu, Zeeshan Fatima* and Saif Hameed*
DOI: 10.2174/1875692116666180405144630